MGM vs XBIO · P/E 64, rev $4.45B vs rev $1.5M
MGM Resorts International (MGM) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
MGM currently screens at market cap $12.01B and trailing P/E 64.3. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the MGM and XBIO stock pages for the full models.
Not investment advice.